This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignees: Universidad Tecnica Particular De Loja, Bioventures, LLC, The United States Government as Represented by the Department of Veterans Affairs. Active years: 2018-2021.
Company Filing History:
3 out of 3 
2 out of 99 
2 out of 952 
Years Active: 2018-2021
Title: Omar Malagon: Innovator in Cancer Treatment and Radioprotection
Introduction
Omar Malagon is a notable inventor based in Loja, Ecuador. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at cancer treatment and radioprotection. With a total of 3 patents, his work reflects a commitment to advancing healthcare solutions.
Latest Patents
One of Malagon's latest patents is focused on dehydroleucodine derivatives and their uses. This invention provides amine derivatives of dehydroleucodine, which are utilized to inhibit the growth of cancer cells. Another significant patent involves the preparation and use of a composition for the prevention and mitigation of the effects of radiation. This composition includes γ-tocotrienol (GT3) and δ-tocotrienol (DT3) in ratios where DT3 predominates, offering potential radioprotection and radiomitigation for individuals in need.
Career Highlights
Throughout his career, Omar Malagon has worked with esteemed institutions such as Universidad Técnica Particular de Loja and the United States Government as represented by the Department of Veterans Affairs. His work in these organizations has allowed him to collaborate on various research projects that aim to improve health outcomes.
Collaborations
Some of his notable coworkers include Cesar M. Compadre and Darin E. Jones. Their collaborative efforts have contributed to the advancement of research in medicinal applications.
Conclusion
Omar Malagon's innovative work in developing cancer treatment and radioprotective compounds showcases his dedication to improving healthcare. His patents reflect a significant impact on the field, and his collaborations further enhance the potential of his research.